“After positive feedback from FDA during our recent Type D meeting, we are excited to initiate start-up activities for the phase 1 clinical trial and are delighted to have found an excellent partner in SAPRO,” said Michael Baker, Chief Executive Officer and Managing Director of Arovella. …
Arovella advances ALA-101 program with CRO appointment and Phase 1 trial preparations
October 29, 2025 Australian Biotech
Latest Video
New Stories
-
Guilt over this enduring failure is the correct response
September 9, 2026 - -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News -
'You can't fix a broken system by tinkering with parts of it'
September 9, 2026 - - Latest News -
A review recommendation that should be reconsidered because of time
September 8, 2026 - - Latest News -
The forgotten patients living in the long shadow of rare cancer
September 8, 2026 - - Latest News -
Pharmacists could save women millions and cut GP queues, new analysis shows
September 8, 2026 - - Latest News